Nathan Hawkey

Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin binding

Suzanne Bartholf DeWitt, Sarah Hoskinson Plumlee, Hailey E. Brighton et al. · JCI Insight · 2022 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +17

Abstract PR008: MYTHIC: First-in-human (FIH) biomarker-driven phase I trial of PKMYT1 inhibitor lunresertib (lunre) alone and with ATR inhibitor camonsertib (cam) in solid tumors with <i>CCNE1</i> amplification or deleterious alterations in <i>FBXW7</i> or <i>PPP2R1A</i>

Timothy A. Yap, Alison M. Schram, Elizabeth K. Lee et al. · Molecular Cancer Therapeutics · 2023 · 20 citations

Medicine, Oncology, Pharmacology +17

A Zebrafish Model of Metastatic Colonization Pinpoints Cellular Mechanisms of Circulating Tumor Cell Extravasation

Tyler A. Allen, Mark M. Cullen, Nathan Hawkey et al. · Frontiers in Oncology · 2021 · 19 citations · Full text

Medicine, Cell Biology, Oncology +17

Prostate-specific membrane antigen-targeted theranostics: past, present, and future approaches.

Nathan Hawkey, Alton Oliver Sartor, Michael J. Morris et al. · PubMed · 2022 · 16 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

The Effects of Glaucoma Drainage Devices on Oxygen Tension, Glycolytic Metabolites, and Metabolomics Profile of Aqueous Humor in the Rabbit

Blake K. Williamson, Nathan Hawkey, Diane A. Blake et al. · Translational Vision Science & Technology · 2018 · 11 citations · Full text

Medicine, Ophthalmology, Veterinary Ophthalmology +16